• Home
  • About
    • About Panaxea
    • Meet our team
    • Careers
  • Services
    • Health Technology Assessment
    • Health Services & Systems Research
    • Health Innovation Assessment Consultancy
  • News & Cases
  • Publications
  • Contact
  • Privacy Statement Panaxea
Health Economic Modeling

Thermo Fisher is a long time client of Panaxea. This resulted among others in a tailor made health economic model for the Procalcitonin (PCT) test manufactured by Thermo Fisher. Results of this model were published in the Journal of Medical Economics.

Recently, a new study was published by De Jong et al. in which new results of the PCT test were described. This article covered some of the economical aspects of adding a PCT to the current care. Because the economic analysis in the De Jong article was with a small perspective, we sent an comment to the Lancet Infectious Diseases , to emphasize that normally an economic analysis is broader than the one performed in the De Jong article. This, to ensure that people interested in the economic value of the PCT test, would see the full picture.

The comment can be found here.

Panaxea b.v. supports decision making in healthcare by assessing the relative advantage of healthcare innovations. Our clients include patients, health and life science innovators and investors, health technology adopters, public and private payers, and policymakers.

Follow us on Twitter

Tweets by @PANAXEA

Useful Links

Home
About Panaxea
Services
Publications
Contact Us

Social Media

 Twitter Linkedin

Contact Information

PANAXEA b.v.
Pettelaarpark 84
5216 PP Den Bosch
The Netherlands

+31 20 7400 778
www.panaxea.eu
info@panaxea.eu

© 2019 Panaxea. All Rights Reserved.
  • Privacy Statement Panaxea
  • No translations available for this page